Pet Pharm Biotech Co (ROCO:7762) Total Inventories : NT$13.7 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co Total Inventories?

Pet Pharm Biotech Co's total inventories for the quarter that ended in Dec. 2024 was NT$13.7 Mil. Pet Pharm Biotech Co's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Dec. 2024 was NT$11.3 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Pet Pharm Biotech Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was NT$4.80.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Pet Pharm Biotech Co's Days Inventory for the six months ended in Dec. 2024 was 60.72.

Inventory Turnover measures how fast the company turns over its inventory within a year. Pet Pharm Biotech Co's Inventory Turnover for the quarter that ended in Dec. 2024 was 3.01.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pet Pharm Biotech Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.15.

Pet Pharm Biotech Co Total Inventories Historical Data

The historical data trend for Pet Pharm Biotech Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co Total Inventories Chart

Pet Pharm Biotech Co Annual Data

Trend

Dec22

Dec23

Dec24

Total Inventories

5.81

10.80

13.68

Pet Pharm Biotech Co Semi-Annual Data
	Dec22	Jun23	Dec23	Jun24	Dec24
Total Inventories	5.81	-	10.80	8.96	13.68

Pet Pharm Biotech Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Pet Pharm Biotech Co (ROCO:7762) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Pet Pharm Biotech Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(387.929	+	0.75 * 33.778	+	0.5 * 13.683	-	177.517
-	0	-	0)	/	50.529
=	4.80

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pet Pharm Biotech Co's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	11.323	/	34.032	*	365 / 2
	=	60.72

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pet Pharm Biotech Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	34.032	/	11.323
	=	3.01

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pet Pharm Biotech Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	11.323	/	74.764
	=	0.15

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Pet Pharm Biotech Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Pet Pharm Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051

Website

https://www.petpharmbio.com

Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines